Home / Indapamide / Czechia
CZ ATC C03BA11 · updated 2 Nov 2026
Indapamide shortage in Czechia
Is there an Indapamide shortage in Czechia?
Yes. As of 2 Nov 2026, 2 Indapamide products are reported short in Czechia, the first since 17 Jan 2024. The company estimate for the return is 31 Dec 2026 (latest 20 Jan 2027). Main reason: commercial decision or withdrawal.
Also short in Canada, Austria, Australia. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | INDAPAMID PMCS 0,625MG 0,625MG TBL NOB 30 | PRO.MED.CS Praha a.s. | 17 Jan 2024 | 20 Jan 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | INDAPAMID PMCS 1,25MG 1,25MG TBL NOB 30 | PRO.MED.CS Praha a.s. | 15 Jun 2026 | 31 Dec 2026 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.